Source: Annual Congress 2006 - Diagnosis of tuberculosis infection and immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Zellweger, P. Wrighton-Smith (Lausanne, Switzerland; Oxford, United Kingdom). Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006; 28: Suppl. 50, 2053

Member's Comments

No comment yet.

Related content which might interest you: Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 35-44 Year: 2006 The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1-3 Year: 2006 Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area Source: Eur Respir J 2015; 46: 165-174 Year: 2015 Frequency of discordant results in interferon-γ release assay serial testing for latent tuberculosis infection in health care workers Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Latent tuberculosis infection in a drug treatment centre Source: Eur Respir J 2002; 20: Suppl. 38, 366s Year: 2002 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 1285 Year: 2006 Completion of treatment for latent tuberculosis infection Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017